ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
Infinium Pharmachem Ltd reported revenue from operations of ₹129.7 Cr (+54.2% YoY) and net profit of ₹8.9 Cr (+58.9% YoY) for H1 FY27.
Infinium Pharmachem Limited filed its quarterly SEBI Regulation 74(5) compliance certificate for the period ending September 30, 2026, confirming all shares are held in demat form.
Infinium Pharmachem Limited submitted its Annual Secretarial Compliance Report for 2026. This filing supports the company's application to migrate from the NSE SME Emerge platform to the Main Board.
Infinium Pharmachem Limited announced that the resolution for migrating its equity shares from the NSE Emerge platform to the mainboard was passed via postal ballot.
ICRA assigned a new [ICRA]BBB (Stable) rating to Infinium Pharmachem's ₹52.20 Crore credit facilities. The assignment covers cash credit, term loans, and unallocated limits from ICICI Bank and SBI.
Infinium Pharmachem Limited held its 22nd Annual General Meeting on September 17, 2026. Shareholders transacted ordinary and special business, including director appointments and remuneration revisions.
Infinium Pharmachem Limited issued a postal ballot notice to seek shareholder approval for migrating its equity shares from the NSE Emerge platform to the main board.
Infinium Pharmachem Limited issued a notice for its Annual General Meeting to be held on September 17, 2026. The meeting agenda includes financial statement adoption and director re-appointments.
Infinium Pharmachem Limited has appointed M/s. Ronak R Jain & Associates as Internal Auditor and M/s. RTBR & Associates as Secretarial Auditor. The company also re-appointed BRS & Associates as Cost Auditor.
Infinium Pharmachem Limited has appointed an Internal Auditor, Secretarial Auditor, and Cost Auditor for the Financial Year 2026-27 to comply with statutory regulatory requirements.
Infinium Pharmachem's board approved migrating from the NSE SME platform to the Main Board, set the AGM date, and appointed new auditors for the upcoming fiscal year.
Infinium Pharmachem Limited has scheduled a board meeting for August 22, 2026, to discuss other business matters.